Postdoctoral Fellow - Hematological Malignancies

Join the forefront of groundbreaking research at the Beckman Research Institute of City of Hope, where we're changing lives and making a real difference in the fight against cancer, diabetes, and other life-threatening illnesses. Our dedicated and compassionate faculty and staff are driven by a common mission: Contribute to innovative approaches in predicting, preventing, and curing diseases, shaping the future of medicine through cutting-edge research.

The Beckman Research Institute of City of Hope is looking for a talented Postdoctoral Fellow under the direction of Dr. Ling Li.

Our dynamic department stands at the forefront of cutting-edge medical research. As a Postdoctoral Fellow, you will actively contribute to groundbreaking projects, employing high-throughput CRISPR genetic screening to unveil novel targets and utilizing single-cell technology for in-depth genome analysis in hematological malignancies. You will also engage in diverse activities, from scrutinizing leukemia evolution to pioneering novel immunotherapies. Join our collaborative lab environment, where innovation and excellence fuel our quest for healthcare advancements tailored to hematological malignancy patients.

For more information about Dr. Ling Li's lab, please visit here.

As a successful candidate you will:

• Perform genotyping.
• Amplify plasmid.
• Procure reagents/supplies.
• Master mouse techniques such as transplantation, extraction of bone marrow cells, and antibody staining.
• Isolate Peripheral Blood/Bone marrow mononuclear cells (PBMC) from Human Acute Myeloid Leukemia (AML) or normal healthy samples and conduct Flow Cytometry for verification only for human specimens.

Your qualifications should include:

• Ph.D. degree in life or biomedical sciences, or a related discipline is required.

City of Hope is an equal opportunity employer. To learn more about our commitment to diversity, equity and inclusion, please click here.

To learn more about our Comprehensive Benefits, pleaseCLICK HERE.